Novid-20 is an Israeli biotechnology startup pioneering a natural approach to antiviral wellness. The company develops plant-derived actives that help reduce viral activity safely and effectively at the oral gateway, the body’s first line of defense. Its flagship technology, Cinnovir, is a patented cinnamon-bark fraction created through a proprietary green-chemistry process that isolates antiviral compounds while excluding undesirable ones. Novid-20’s initial focus is B2B white-label functional candy, enabling partners to launch immune-supporting products backed by science and natural efficacy. Its long-term vision for Cinnovir to commercialize it as a hero ingredient platform for functional foods and pet-care wellness applications, reclaiming wellness from viruses, naturally. Building on this, the company is developing a pipeline of natural oral-care innovations designed to restore virome balance, improving the oral microbiome, driving systemic wellness benefits, all as part of enjoyable daily routines.